Carcaterrra Maurizio, Osti Martia Falchetto, De Sanctis Vitaliana, Caruso Cristina, Berardi Francesca, Enrici Riccardo Maurizi
U.O.C. Radioterapia Oncologica, Università La Sapienza, Roma, Italy.
Rays. 2005 Oct-Dec;30(4):319-22.
Surgical resection remains the mainstay treatment for esophageal cancer and the failure of surgery alone is attributed to the systemic nature of the disease at the time of presentation. In an effort to improve local control of the disease that should correspond to a benefit in survival, postoperative adjuvant schemes of treatment have been explored. Current standard treatment, and future implications in light of the new knowledge are analyzed, based on the present literature. The possibility of different treatments in relation to different histology findings, is stressed.
手术切除仍然是食管癌的主要治疗方法，单纯手术失败归因于疾病在确诊时已具有全身性。为了提高对疾病的局部控制，而这应该会带来生存获益，人们探索了术后辅助治疗方案。基于现有文献，分析了当前的标准治疗方法以及鉴于新知识所带来的未来影响。强调了根据不同组织学结果采取不同治疗方法的可能性。
